Free Trial

Lam Research (LRCX) Stock Forecast & Price Target

Lam Research logo
$78.55 +3.29 (+4.38%)
As of 01:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Lam Research - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
5
Buy
17

Based on 22 Wall Street analysts who have issued ratings for Lam Research in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 5 have given a hold rating, and 17 have given a buy rating for LRCX.

Consensus Price Target

$98.22
25.03% Upside
According to the 22 analysts' twelve-month price targets for Lam Research, the average price target is $98.22. The highest price target for LRCX is $125.00, while the lowest price target for LRCX is $75.00. The average price target represents a forecasted upside of 25.03% from the current price of $78.55.
Get the Latest News and Ratings for LRCX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lam Research and its competitors.

Sign Up

LRCX Analyst Ratings Over Time

TypeCurrent Forecast
3/14/24 to 3/14/25
1 Month Ago
2/13/24 to 2/12/25
3 Months Ago
12/15/23 to 12/14/24
1 Year Ago
3/15/23 to 3/14/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
17 Buy rating(s)
16 Buy rating(s)
13 Buy rating(s)
14 Buy rating(s)
Hold
5 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$98.22$95.72$97.24$81.17
Forecasted Upside25.03% Upside17.34% Upside27.51% Upside-12.32% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Remove Ads

LRCX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LRCX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lam Research Stock vs. The Competition

TypeLam ResearchComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.77
2.68
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside26.07% Upside120.83% Upside22.08% Upside
News Sentiment Rating
Positive News

See Recent LRCX News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/20/2025Mizuho
2 of 5 stars
Vijay Rakesh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$87.00 ➝ $100.00+11.81%
2/20/2025Susquehanna
2 of 5 stars
Mehdi Hosseini
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Positive$75.00 ➝ $125.00+42.60%
2/18/2025Cantor Fitzgerald
4 of 5 stars
C. Muse
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$100.00 ➝ $100.00+20.85%
1/30/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Charles Shi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$90.00 ➝ $90.00+19.76%
1/30/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joseph Quatrochi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$82.00 ➝ $85.00+13.11%
1/30/2025Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Rasgon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$85.00 ➝ $91.00+21.09%
1/17/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Tom O'Malley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$90.00 ➝ $75.00-5.33%
1/17/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Steve Barger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$95.00 ➝ $95.00+19.92%
1/15/2025Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Chris Caso
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
1/10/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Toshiya Hari
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$96.00 ➝ $85.00+13.14%
12/5/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$76.00 ➝ $78.00+0.13%
10/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ramel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
10/24/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$105.00 ➝ $100.00+32.45%
10/23/2024B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Ellis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$132.50 ➝ $105.00+44.13%
9/16/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$99.00 ➝ $89.30+18.88%
9/12/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$125.00 ➝ $115.00+53.89%
8/1/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$110.00 ➝ $95.00+15.45%
8/1/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $105.00+13.98%
6/7/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$95.00 ➝ $106.00+9.93%
5/13/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy ➝ Buy$98.00 ➝ $110.00+20.16%
4/25/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$90.00 ➝ $95.00+5.04%
4/16/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$120.00+26.83%
11/22/2023Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$80.00+13.09%
4/20/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$53.00 ➝ $55.50+6.92%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:26 PM ET.


Should I Buy Lam Research Stock? LRCX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, March 9, 2025. Please send any questions or comments about these Lam Research pros and cons to contact@marketbeat.com.

Lam Research
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Lam Research Co.:

  • Lam Research Co. recently reported earnings per share of $0.91, exceeding the consensus estimate of $0.87, indicating strong financial performance and effective management.
  • The company has a high return on equity of 51.86%, suggesting that it is efficient in generating profits from its equity investments, which is attractive to investors looking for strong returns.
  • Lam Research Co. has declared a quarterly dividend of $0.23, with a dividend yield of 1.16%. This provides a steady income stream for investors, enhancing the overall return on investment.
  • Recent analyst upgrades have been positive, with several firms raising their price targets, indicating confidence in the company's future performance. The average target price is currently $98.22, suggesting potential for stock appreciation.
  • The current stock price is $79.01, which may present a buying opportunity for investors looking to enter at a lower price before potential gains as the market recognizes the company's value.

Lam Research
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Lam Research Co. for these reasons:

  • Despite recent positive earnings, the stock has experienced volatility, with a 1-year low of $68.87, which may indicate underlying risks in the market or sector.
  • Insider selling has been noted, with a senior vice president selling 110,080 shares, which could signal a lack of confidence in the company's short-term prospects.
  • The semiconductor industry is highly competitive and subject to rapid technological changes, which could impact Lam Research Co.'s market position and profitability.
  • With 84.61% of the stock owned by institutional investors, there may be less room for retail investors to influence the stock price, potentially leading to less favorable trading conditions.
  • The company's debt-to-equity ratio is 0.51, which, while manageable, indicates that Lam Research Co. does carry some debt, which could be a concern if market conditions worsen.

LRCX Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Lam Research is $98.22, with a high forecast of $125.00 and a low forecast of $75.00.

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lam Research in the last twelve months. There are currently 5 hold ratings and 17 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" LRCX shares.

According to analysts, Lam Research's stock has a predicted upside of 25.03% based on their 12-month stock forecasts.

Over the previous 90 days, Lam Research's stock had 4 upgrades and 1 downgrade by analysts.

Analysts like Lam Research more than other "computer and technology" companies. The consensus rating score for Lam Research is 2.77 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how LRCX compares to other companies.


This page (NASDAQ:LRCX) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners